Allergic conditions

Allergic rhinitis

  • Structured review of medication adherence in allergic rhinitis compared with other treatments for chronic conditions
  • Communications and manuscript on a survey of the impact of allergic rhinitis on sleep
  • Review of PROs and development of a patient-reported screening tool in allergic rhinitis
  • Preference questionnaire on allergic rhinitis spray devices
  • Comparative preference trial with an experience questionnaire in allergic rhinitis
  • Focus groups assessing patient experience with nasal spray in allergic rhinitis, analysis of results and development of a report on concept elicitation and cognitive debriefing
  • Literature research and communications on the burden of nasal blockage in allergic rhinitis
  • Validation of the preference module of the Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q), with revisions to an FDA briefing document on the development and validation of the EARNS-Q experience and preference modules
  • Manuscript on the development of the EARNS-Q
  • Regulatory support for the EARNS-Q

Other allergic conditions

  • Structured literature review for allergy immunotherapy, including medication adherence compared to other treatments
  • Systematic literature review in allergy immunotherapy products
  • Survey of the impact of allergy on sleep (including literature review and HCP interviews)
  • Portfolio value proposition and literature review on allergy immunotherapy
  • Abstracts and posters for allergy immunotherapy compliance in allergic rhinitis
  • Cost effectiveness analysis of allergy immunotherapy products
  • Internal value communication deck on real world studies in allergic reactions
  • Analysis of phase II symptom data in a study of lactose intolerance
  • Development of a COA strategy to measure treatment side effects for peanut allergy treatments

Eosinophilic esophagitis

  • Development and validation of a PRO measure in paediatric patients with eosinophilic esophagitis
  • Qualitative interviews to develop a symptom measure in adult patients with eosinophilic esophagitis
  • Re-analysis of qualitative data and cognitive debriefing interviews to create a symptom measure in esonophilic esophagitis
  • Analysis of a field trial on eosinophilic esophagitis
  • Cognitive debriefing and modification of the Eosinophilic Esophagitis Activity Index (EEsAI)
  • Modification of the Eosinophilic Esophagitis Activity Index (EEsAI)

Angioedema

  • Telephone consultation on angioedema
  • Strategic PRO and ObsRO consulting of an angiotensin converting enzyme (ACE) inhibitor induced angioedema clinical trial database
  • Cognitive debriefing interviews in ACE inhibitor induced angioedema
  • Investigator training for the ACE inhibitor induced angioedema investigator rating scale
  • Translation and linguistic validation of clinician assessments in ACEI-Angioedema
  • Communications on clinician assessments in ACEI-Angioedema